Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113336692B details a copper-catalyzed bicyclization of 1,6-dienes. This method offers high yields and diastereoselectivity for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for high-purity imidazoles. Reduces cost and improves supply chain reliability for pharma manufacturing.
Novel cascade reaction method for high-yield pyrrole derivatives. Efficient scale-up and cost-effective raw materials for pharmaceutical intermediates.
Patent CN112898202A details a mild visible-light photocatalytic method for synthesizing heterocyclyl cyclopropane compounds, offering significant advantages for pharmaceutical intermediate manufacturing.
Electrochemical preparation of selenium-containing thiazolines via patent CN111235596A. Mild conditions, high purity, ideal for reliable pharmaceutical intermediate supply chains.
Novel one-pot method for beta-substituted azlactone derivatives eliminates phosphorus waste, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111423381B reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced cost efficiency.
Patent CN113636968B details a novel ruthenium-catalyzed route for 3-acylpyrroles, offering superior atom economy and simplified purification for pharmaceutical manufacturing.
Novel nickel-catalyzed method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing without toxic carbon monoxide gas usage globally.
Novel light-induced patent CN116606239B enables metal-free synthesis. Delivers high-purity intermediates with reduced costs and scalable supply chain solutions.
Patent CN118271227B reveals silver-catalyzed synthesis for high-purity pyrrole intermediates offering cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN111423381B details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering high efficiency and cost-effective manufacturing for pharma intermediates.
Patent CN113620795B details a novel Rh-catalyzed route to benzocycloheptenones. Discover cost-effective manufacturing and scalable API intermediate production strategies.
Novel axial chiral bisindole catalyst synthesis offers high enantioselectivity and mild conditions for cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain.
Patent CN111471026A details a base-promoted cyclization of nitriles and hydrazines. Offers mild conditions, high yields, and scalable production for pharmaceutical intermediates.
Patent CN114920707B reveals a novel iodine-promoted synthesis using DMF as both solvent and carbon source, offering significant cost reduction in API manufacturing and simplified scale-up.
Novel Rh-catalyzed one-step synthesis of 1,2,5-polysubstituted imidazoles. High atom economy, scalable process for reliable pharmaceutical intermediate supply chain.
Patent CN112239456B details a novel Pd-catalyzed carbonylation for 2,3-dihydroquinolones. This method offers high efficiency, broad substrate scope, and significant cost reduction in API manufacturing.
Novel thiourea catalyzed route offers high stereoselectivity and metal-free production for pharmaceutical intermediates ensuring supply chain reliability.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones using chiral phosphoric acid, offering cost-effective solutions for API manufacturing.